These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 16237115)

  • 1. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis.
    Numasaki M; Watanabe M; Suzuki T; Takahashi H; Nakamura A; McAllister F; Hishinuma T; Goto J; Lotze MT; Kolls JK; Sasaki H
    J Immunol; 2005 Nov; 175(9):6177-89. PubMed ID: 16237115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer.
    Põld M; Zhu LX; Sharma S; Burdick MD; Lin Y; Lee PP; Põld A; Luo J; Krysan K; Dohadwala M; Mao JT; Batra RK; Strieter RM; Dubinett SM
    Cancer Res; 2004 Mar; 64(5):1853-60. PubMed ID: 14996749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer.
    Keshamouni VG; Arenberg DA; Reddy RC; Newstead MJ; Anthwal S; Standiford TJ
    Neoplasia; 2005 Mar; 7(3):294-301. PubMed ID: 15799829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis.
    Addison CL; Arenberg DA; Morris SB; Xue YY; Burdick MD; Mulligan MS; Iannettoni MD; Strieter RM
    Hum Gene Ther; 2000 Jan; 11(2):247-61. PubMed ID: 10680839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer.
    Arenberg DA; Keane MP; DiGiovine B; Kunkel SL; Morris SB; Xue YY; Burdick MD; Glass MC; Iannettoni MD; Strieter RM
    J Clin Invest; 1998 Aug; 102(3):465-72. PubMed ID: 9691082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer.
    Keane MP; Belperio JA; Xue YY; Burdick MD; Strieter RM
    J Immunol; 2004 Mar; 172(5):2853-60. PubMed ID: 14978086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism.
    Loukinova E; Dong G; Enamorado-Ayalya I; Thomas GR; Chen Z; Schreiber H; Van Waes C
    Oncogene; 2000 Jul; 19(31):3477-86. PubMed ID: 10918606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic AMP-responsive element binding protein- and nuclear factor-kappaB-regulated CXC chemokine gene expression in lung carcinogenesis.
    Sun H; Chung WC; Ryu SH; Ju Z; Tran HT; Kim E; Kurie JM; Koo JS
    Cancer Prev Res (Phila); 2008 Oct; 1(5):316-28. PubMed ID: 19138976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis.
    Addison CL; Belperio JA; Burdick MD; Strieter RM
    BMC Cancer; 2004 Jun; 4():28. PubMed ID: 15214968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity.
    White ES; Strom SR; Wys NL; Arenberg DA
    J Immunol; 2001 Jun; 166(12):7549-55. PubMed ID: 11390510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases.
    Arenberg DA; Kunkel SL; Polverini PJ; Morris SB; Burdick MD; Glass MC; Taub DT; Iannettoni MD; Whyte RI; Strieter RM
    J Exp Med; 1996 Sep; 184(3):981-92. PubMed ID: 9064358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of human T cells that regulate neutrophilic skin inflammation.
    Schaerli P; Britschgi M; Keller M; Steiner UC; Steinmann LS; Moser B; Pichler WJ
    J Immunol; 2004 Aug; 173(3):2151-8. PubMed ID: 15265952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetics underpinning the regulation of the CXC (ELR+) chemokines in non-small cell lung cancer.
    Baird AM; Gray SG; O'Byrne KJ
    PLoS One; 2011 Jan; 6(1):e14593. PubMed ID: 21298036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversity of the angiogenic phenotype in non-small cell lung cancer.
    McClelland MR; Carskadon SL; Zhao L; White ES; Beer DG; Orringer MB; Pickens A; Chang AC; Arenberg DA
    Am J Respir Cell Mol Biol; 2007 Mar; 36(3):343-50. PubMed ID: 17079777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis.
    Khan MN; Wang B; Wei J; Zhang Y; Li Q; Luan X; Cheng JW; Gordon JR; Li F; Liu H
    Oncotarget; 2015 Aug; 6(25):21315-27. PubMed ID: 26087179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer.
    Arenberg DA; Polverini PJ; Kunkel SL; Shanafelt A; Hesselgesser J; Horuk R; Strieter RM
    J Leukoc Biol; 1997 Nov; 62(5):554-62. PubMed ID: 9365108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer.
    Wang D; Wang H; Brown J; Daikoku T; Ning W; Shi Q; Richmond A; Strieter R; Dey SK; DuBois RN
    J Exp Med; 2006 Apr; 203(4):941-51. PubMed ID: 16567391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer.
    Ge G; Wang A; Yang J; Chen Y; Yang J; Li Y; Xue Y
    J Exp Clin Cancer Res; 2016 Jan; 35():13. PubMed ID: 26791086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved survival in tumor-bearing SCID mice treated with interferon-gamma-inducible protein 10 (IP-10/CXCL10).
    Arenberg DA; White ES; Burdick MD; Strom SR; Strieter RM
    Cancer Immunol Immunother; 2001 Dec; 50(10):533-8. PubMed ID: 11776375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apelin expression in human non-small cell lung cancer: role in angiogenesis and prognosis.
    Berta J; Kenessey I; Dobos J; Tovari J; Klepetko W; Jan Ankersmit H; Hegedus B; Renyi-Vamos F; Varga J; Lorincz Z; Paku S; Ostoros G; Rozsas A; Timar J; Dome B
    J Thorac Oncol; 2010 Aug; 5(8):1120-9. PubMed ID: 20581707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.